Anti-Mouse CD154 In Vivo Antibody - Ultra Low Endotoxin
Introducing the Anti-Mouse CD154 In Vivo Antibody - Ultra Low Endotoxin from Assay Genie,** a highly specific monoclonal antibody designed for in vivo applications. This antibody targets the CD154 protein, crucial in immune response, making it ideal for research in immunology and related fields. With its high specificity and ultra-low endotoxin levels (<1.0 EU/mg), it ensures minimal immune response interference, perfect for ELISA, flow cytometry, immunohistochemistry, and other assays. Available in various sizes, it is formulated in phosphate-buffered saline for stability and efficacy.
Enhance your research with this reliable and versatile antibody. CD154, also known as CD40 ligand, is a protein found on the surface of various immune cells, including T-helper cells. It plays a significant role in the immune system by assisting the activation of B cells through interaction with CD40, leading to immune responses like antibody production. This makes the Anti-Mouse CD154 antibody a valuable tool for studying immune mechanisms and diseases.
Product Name:
Anti-Mouse CD154 In Vivo Antibody - Ultra Low Endotoxin
Product Code:
IVMB0317
Size:
0.5 mg, 1 mg, 5 mg
Clone:
MR1
Protein:
CD154
Product Type:
Monoclonal Antibody
Synonyms:
CD40L, TRAP, T-BAM, CD40
Isotype:
IgG
Reactivity:
Mouse
Applications:
B, FC, IHC FF, In Vivo, WB
Formulation:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Endotoxin Level:
<0.5 EU/mg as determined by the LAL method
Purity:
≥98% monomer by analytical SEC ⋅ >95% by SDS Page
Product Preparation:
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Applications:
B, FC, IHC FF, In Vivo, WB
Reactivity:
Mouse
Host Species:
Armenian Hamster
Specificity:
Clone MR1 recognizes an epitope on mouse CD154.
Antigen Distribution:
CD154 is expressed on activated CD4+ T cells.
Immunogen:
Activated mouse Th1 clone D1.6
Concentration:
1.0 - 5.0 mg/ml
Endotoxin Level:
<0.5 EU/mg as determined by the LAL method
Formulation:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Purity:
≥98% monomer by analytical SEC ⋅ >95% by SDS Page
Preparation:
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
CD40 is a 48 kD type I transmembrane glycoprotein that is a member of the TNFR superfamily. CD40, in association with its ligand CD154 (CD40L) - a 39 kD protein, acts as a costimulatory molecule for the activation of B cells, dendritic cells, monocytes, and other antigen presenting cells. CD40 is involved in Ig isotype switching and dendritic cell maturation, as well as the activation, differentiation and proliferation of B cells. CD40 interacts with TNFR2 and is involved in the regulation of signal transduction. CD40 is a potential target for cancer immunotherapy. Blocking the interaction of CD40 with its ligand (CD154) is the sought-after therapeutic objective for preventing and/or improving both autoimmune diseases and transplant rejection. Studies have shown that monoclonal antibodies that block CD154 in human clinical trials resulted in unanticipated vascular complications. Hence, an interest in the therapeutic potential for antagonist mAbs specific for human CD40 is emerging. Antibodies of particular therapeutic interest are those that do not inhibit CD40 signaling via physical competition with CD154. Additionally, the interaction of CD40 and its ligand (CD154) is found to be essential for amyloid-beta-induced microglial activation, thus plays a significant part in Alzheimer disease pathogenesis.
Protein:
CD154
Ligand/Receptor:
CD40
Pathogen Testing:
To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Assay Genie's Purified Functional Antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile.
